Human corneal stromal stem cells express anti-fibrotic microRNA-29a and 381-5p – A robust cell selection tool for stem cell therapy of corneal scarring
Introduction: Corneal blindness due to scarring is treated with corneal transplantation. However, a global problem is the donor material shortage. Preclinical and clinical studies have shown that cell-based therapy using corneal stromal stem cells (CSSCs) suppresses corneal scarring, potentially med...
Main Authors: | Gary Hin-Fai Yam, Tianbing Yang, Moira L Geary, Mithun Santra, Martha Funderburgh, Elizabeth Rubin, Yiqin Du, Jose A Sahel, Vishal Jhanji, James L Funderburgh |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-03-01
|
Series: | Journal of Advanced Research |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2090123222001205 |
Similar Items
-
Good manufacturing practice production of human corneal limbus-derived stromal stem cells and in vitro quality screening for therapeutic inhibition of corneal scarring
by: Mithun Santra, et al.
Published: (2024-01-01) -
Regenerative Therapy for Corneal Scarring Disorders
by: Christine Chandran, et al.
Published: (2024-03-01) -
A Full Good Manufacturing Practice–Compliant Protocol for Corneal Stromal Stem Cell Cultivation
by: Mithun Santra, et al.
Published: (2024-09-01) -
Mesenchymal stem cell exosomes as immunomodulatory therapy for corneal scarring
by: Ong, Hon Shing, et al.
Published: (2023) -
Intrastromal autologous implantation of adipose derived adult stem cells for the management of established corneal scars
by: Jorge L. Alio del Barrio, et al.
Published: (2025-03-01)